Martin Schuler

34PUBLICATIONS

250CO-AUTHORS

Molecular targetsParticle physicsImage processingPredictive and prognostic markersCancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (34)

Sort by Publication Date:

|Jul 15, 2026

Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

|Mar 28, 2026

Radiation Dose-Dependent and -Independent Pulmonary Infiltrates in Patients with High-Grade Pneumonitis After Radiochemotherapy and Durvalumab Consolidation for Stage III NSCLC.

Andreas Herz, Aymane Khouya, Maja Guberina

|Mar 11, 2026

Automated Tumor International Classification of Diseases Coding of Real-World Pathology Reports Using Self-Hosted Large Language Models.

Kamyar Arzideh, René Hosch, Amin Turki

|Jan 05, 2026

Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal Cancer.

Julius Keyl, René Hosch, Fabian Hörst

|Oct 28, 2025

Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression.

Luca Hegedüs, Silvia Qaisieh, Christian Stülpnagel

|May 28, 2025

Molecular determinants of sotorasib clinical efficacy in KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer.

Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen

Pageof 6

Frequent Collaborators

Fabian Dörr

Servet Bölükbas

Kaid Darwiche

Stefan Kasper

M Tewes

J Hense

M Teufel

Georg Schlachtenberger

3 joint publications

Viktor Grünwald

3 joint publications

Balazs Hegedüs

Frequent Collaborators

Fabian Dörr

Servet Bölükbas

Kaid Darwiche

Stefan Kasper